Israeli biotech IceCure Medical has received $21 million of funds from Epoch Partner Investments to speed up the sales and distribution of its IceSense3 cryoablation system to treat breast cancer. IceSense3 uses extreme cold to destroy targeted tumors in less than 15 mins, with no pain.

http://jewishbusinessnews.com/2015/02/17/israeli-icecure-gets-21-2-million-international-investment-to-treat-breast-cancer-with-extreme-cold/